Another controversy is related to the STC2 gene, which is also upregulated in the responders (13), while other studies indicate that STC2 is a positive regulator of metastasis and poorer prognosis in HNSCC (74) and pancreatic cancer (75). Here, STC2 is linked to familial pancreatic carcinoma.